Dapaxifra Tablet
Marketer
Effra Lifesciences
Salt Composition
Dapagliflozin (10mg)
Overview Dapaxifra Tablet
GlycemaControl tablets are indicated, either independently or in conjunction with other therapies, for the management of type 2 diabetes. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to cardiovascular health. GlycemaControl can be administered with or without food, consistently at the same time each day, as prescribed by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation may lead to hyperglycemia and potentially serious consequences such as renal impairment or vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, upper respiratory tract infections, and urinary tract infections. Dehydration is a potential risk; ensure adequate hydration. Practicing good hygiene minimizes the chance of genital fungal infections. Prior to commencing treatment, discuss any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Limit alcohol consumption, as excessive intake may heighten the likelihood of certain side effects. Regular blood glucose monitoring is essential during treatment.
Uses of Dapaxifra Tablet
Managing Type 2 Diabetes
Major Benefits of Dapaxifra Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dapaxifra Tablet. Always swallow the tablet whole; avoid chewing, crushing, or breaking it. While Dapaxifra Tablet can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Dapaxifra Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapaxifra Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaxifra Tablets can be consumed with or without food, although consistent timing is recommended.
How Dapaxifra Tablet works:
Dapaxifra tablets manage blood sugar levels. Their mechanism involves urinary excretion of excess glucose.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Dapaxifra Tablet should not be consumed together due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Dapaxifra Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Using Dapaxifra tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired if your blood glucose level is abnormally low or elevated. Refrain from driving should these conditions arise.
KidneyUNSAFE
Individuals with kidney impairment should likely abstain from Dapaxifra Tablet due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Dapaxifra tablets pose no safety concerns for individuals with hepatic impairment; no dosage modification is necessary.
What if you forget to take Dapaxifra Tablet :
Should you forget a Dapaxifra Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapaxifra Tablet
| Label | Value |
|---|---|
| Chemical Classification | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |



